The exploration of B cell maturation antigen expression in plasma cell dyscrasias beyond multiple myeloma

BACKGROUND: B cell maturation antigen (BCMA) targeted immunotherapies have demonstrated remarkable clinical efficacy in multiple myeloma (MM). Here, we evaluated the BCMA expression in MM and other plasma cell dyscrasias (PCDs), hoping to provide a potential treatment strategy for the relapsed/refra...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yanjie, Mao, Xia, Que, Yimei, Xu, Menglei, Li, Chunhui, Almeida, Varlene Daniela Fernandes, Wang, Di, Li, Chunrui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903528/
https://www.ncbi.nlm.nih.gov/pubmed/36750969
http://dx.doi.org/10.1186/s12885-023-10591-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903528/
https://www.ncbi.nlm.nih.gov/pubmed/36750969
http://dx.doi.org/10.1186/s12885-023-10591-1

Ejemplares similares